Jack Tasse
Director of Finance/CFO chez DELIVRA HEALTH BRANDS INC.
Fortune : 31 200 $ au 31/03/2024
Profil
Jack Tasse currently works at Standard Mercantile Acquisition Corp., as Chief Financial Officer from 2021 and Delivra Health Brands, Inc., as Chief Financial Officer & Secretary from 2020.
Mr. Tasse also formerly worked at Therapure Biopharma, Inc., as Finance Director from 2012 to 2016 and Molecular Science Corp., as Chief Financial Officer from 2018 to 2020.
Mr. Tasse received his graduate degree from Brock University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/12/2023 | 1 300 000 ( 0,42% ) | 31 200 $ | 31/03/2024 |
Postes actifs de Jack Tasse
| Sociétés | Poste | Début |
|---|---|---|
| DELIVRA HEALTH BRANDS INC. | Director of Finance/CFO | 01/12/2020 |
| TREZ CAPSNRMTG INV A | Director of Finance/CFO | 01/01/2021 |
Anciens postes connus de Jack Tasse
| Sociétés | Poste | Fin |
|---|---|---|
Molecular Science Corp.
 Molecular Science Corp. Miscellaneous Commercial ServicesCommercial Services Molecular Science Corp. provides laboratory services. The firm offers GC-MS and LC-MS analysis, cannabis laboratory testing services, mobile testing services, and scientific resources. The company was founded by Scott R. Walters and Sameet Kanade on January 24, 2017 and is headquartered in Toronto, Canada. | Director of Finance/CFO | 01/03/2020 |
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Director of Finance/CFO | 01/01/2016 |
Formation de Jack Tasse
| Brock University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREZ CAPSNRMTG INV A | Finance |
| Entreprise privées | 3 |
|---|---|
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
| Delivra Health Brands, Inc. | |
Molecular Science Corp.
Molecular Science Corp. Miscellaneous Commercial ServicesCommercial Services Molecular Science Corp. provides laboratory services. The firm offers GC-MS and LC-MS analysis, cannabis laboratory testing services, mobile testing services, and scientific resources. The company was founded by Scott R. Walters and Sameet Kanade on January 24, 2017 and is headquartered in Toronto, Canada. | Commercial Services |
